15 high-cost drugs, including Ozempic, get major Medicare price reductions in latest negotiation round

The cuts stem from the Inflation Reduction Act, not Trump’s “most favored nation” approach, and apply to what Medicare pays drugmakers. A wave of vital prescription drugs is about to get a lot cheaper for people on Medicare.